Delivery Order SPE2DB20D1100-SPE2DB25FD7Z6
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,845.42 on August 5, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units). This is a firm fixed-price, non-set-aside contract with a completion date of August 6, 2025, and performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order was issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of OxyContin ER 20 mg tablets in quantities of 100 units. This contract is valued at $2,284.62 under a firm fixed-price delivery order arrangement with no set-aside designation, indicating the award was made through open competition. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,924.20 for OxyContin ER 10 mg tablets (100-count) with an ultimate completion date of July 30, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100 count) valued at $2,707.18, with a firm fixed price structure and completion deadline of August 4, 2025. This non-set-aside award, issued on August 1, 2025, represents a single delivery order under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for OxyContin ER 10 mg tablets (100-count units) valued at $1,494.12. This is a firm fixed price delivery order with an ultimate completion date of August 12, 2025, to be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made without a set-aside designation, indicating it was competitively awarded. This delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) valued at $1,228.74, with a firm fixed price arrangement and an ultimate completion date of July 31, 2025. This non-set-aside, competitively awarded contract represents a single delivery order executed on July 30, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of OxyContin ER 20 mg tablets in quantities of 100 units. This firm fixed-price delivery order, valued at $3,215.82, represents a non-competitive set-aside contract with an ultimate completion date of July 28, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency (DLA) awarded a $2,142.97 delivery order to AmerisourceBergen Drug Corp for OxyContin ER 30 mg tablets (100-count packages) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract, which received no set-aside designation, was competitively awarded and represents a child delivery order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical will be supplied from the vendor's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of OxyContin ER 20 mg tablets in quantities of 100 units. The contract is valued at $3,667.68 with a firm fixed-price structure and is scheduled for completion by August 6, 2025. This competitively awarded delivery order carries no set-aside designation and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,046.76 to AmerisourceBergen Drug Corp for the supply of OxyContin ER 20 mg tablets (100-count units) with an ultimate completion date of August 6, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a delivery order against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999.99M and extends through...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD7Z6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,208.27 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare procurement. The company maintains an extensive portfolio of federal medical supply contracts with the Defense Logistics Agency, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for controlled pharmaceutical pain management medication supports DLA's medical supply chain operations for Defense Health Agency customers and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/1/25 |